Iron in the Tumor Microenvironment-Connecting the Dots

Cites (423)

Items 401–416 of 416

1. Chaperone turns gatekeeper: PCBP2 and DMT1 form an iron-transport pipeline
   Darius J.R. Lane, Des Raymond Richardson · 2014 · Biochemical Journal
2. Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
   José A. Rodríguez, Rosendo Lurı́a-Pérez, Héctor Eduardo López-Valdés, David Casero, Tracy R. Daniels‐Wells, Shabnum Patel, David Avila, Richard Kemper Leuchter, Sokuntheavy So, Elizabeth Ortíz-Sánchez et al. · 2011 · Leukemia & lymphoma/Leukemia and lymphoma
3. Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
   William H. Chappell, Saverio Candido, Stephen Lee Abrams, Suzanne M. Russo, Roger Ove, Alberto Maria Martelli, Lucio Cocco, Giulia Ramazzotti, Melchiorre Cervello, Giuseppe Montalto et al. · 2018 · Advances in Biological Regulation
4. Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway
   Sreekanth Kumandan, Navin R. Mahadevan, Kevin Chiu, Alexandra A. DeLaney, Maurizio Zanetti · 2012 · Cancer Letters
5. Unidirectional upregulation of the synthesis of the major iron proteins, transferrin-receptor and ferritin, in HepG2 cells by the acute-phase protein α1-antitrypsin
   Ivo W. Graziadei, Günter Weiß, Anette Bohm, Gabriele Werner‐Felmayer, Wolfgang Vogel · 1997 · Journal of Hepatology
6. Immunity and autoimmunity: revising the concepts of response to breast cancer
   Giuseppe Curigliano · 2011 · The Breast
7. Hypoxia: dual effect on the expression of transferrin receptor in human melanoma A375 cell line
   Juan Tao, Yeqiang Liu, Yan Li, Ji‐ling Peng, Li Li, Jing Liu, Xin Shen, Guanxin Shen, Yating Tu · 2007 · Experimental Dermatology
8. Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy
   Emma Niméus, Johan A. Malmström, Anders Johnsson, György Marko‐Varga, Mårten Fernö · 2006 · Journal of Pharmaceutical and Biomedical Analysis
9. Is there any role of intravenous iron for the treatment of anemia in cancer?
   Cengiz Gemici, O. Yetmen, Gökhan Yaprak, Sevgi Özden, Hüseyin Tepetam, Hazan Özyurt, Alpaslan Mayadağlı · 2016 · BMC Cancer
10. Iron repletion attenuates the protective effects of iron deficiency in DMBA‐induced mammary tumors in rats
    Deborah Hrabinski, Jacqueline L. Hertz, Chris Tantillo, Vance Berger, Adria Rothman Sherman · 1995 · Nutrition and Cancer
11. Importance of erythropoetin receptor expression in tumour tissue for the clinical course of breast cancer.
    Birgit Volgger, Katharina Kurz, Kathrin Zöschg, Igor Theurl, Alexandra Ciresa-König, Christian Marth, Günter Weiß · 2010 · PubMed
12. Iron deficiency in patients with solid tumours: prevalence and management in clinical practice
    Javier de Castro, Pere Gascón, Ana Casas, José Muñoz-Langa, Vicente Alberola, Mercedes Cucala, F. Barón · 2014 · Clinical & Translational Oncology
13. Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells
    Nathalie Scheers, Dora I. A. Pereira, Nuno Faria, Jonathan J. Powell · 2018 · Oncotarget
14. Liver transplantation: An “ in vivo ” model for the pathophysiology of hemochromatosis?†
    Kris V. Kowdley · 2004 · Hepatology
15. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
    Marek Baltaziak, Mariusz Koda, Andrzej Wincewicz, MARIOLA SULKOWSKA, Mariusz Koda, Stanislaw Sulkowski · 2009 · PubMed
16. Anticoagulation, ferrotoxicity and the future of translational lung cancer research
    Leo R. Zacharski · 2016 · Translational Lung Cancer Research